Kanjinti
List of products in the National Drug Code with proprietary name kanjinti. Trastuzumab is used to treat certain breast or stomach cancers that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
55513-132 | Kanjinti | Trastuzumab-anns | Injection, Powder, Lyophilized, For Solution | Intravenous | Amgen Inc | Human Prescription Drug |
55513-141 | Kanjinti | Trastuzumab-anns | Injection, Powder, Lyophilized, For Solution | Intravenous | Amgen Inc | Human Prescription Drug |
55513-164 | Kanjinti | Trastuzumab-anns | Kit | Amgen Inc | Human Prescription Drug |